The S&P/ASX Small Ordinaries Index (XSO) rose to 3,863.40, up 24.30 points or 0.63% on the day, and 2.09% higher over five days.
Quarterlies are starting to trickle in and you can read about the following and more throughout the day.
- Buru Energy Ltd (ASX:BRU, OTC:BRNGF) completed its Share Purchase Plan first announced on September 8, 2025, issuing 69.2 million new shares to raise about A$1.4 million. As applications totalled less than A$3 million, the board may place the shortfall with third-party investors, subject to legal requirements.
- Alkane Resources Ltd (ASX:ALK, OTC:ALKEF) produced 36,407 ounces of gold equivalent for the quarter ended 30 September 2025, a period that included expected slower output at Björkdal during Sweden’s extended summer vacation. Quarter-end liquidity comprised cash of A$160 million, bullion of A$14 million and listed investments of A$17 million (total A$191 million). The company repaid A$45 million of debt, incurred one-off merger costs of A$25 million related to Mandalay, and fulfilled hedging of 7,250 ounces of gold. Further detail will appear in the September 2025 quarterly report later this month.
- Orthocell Ltd (ASX:OCC, OTC:ORHHF) reported record quarterly revenue of A$3.0 million for the September 2025 quarter, up 11% on the June quarter’s A$2.7 million and 50% year-on-year from A$2.0 million, reflecting growing adoption of Striate+ and Remplir.
- Prescient Therapeutics Ltd (ASX:PTX, OTC:PSTTF) ended the quarter with cash of A$12.3 million (A$6.9 million at 30 June 2025). Net operating cash outflow was A$4.1 million, including A$2.8 million invested in research and development and clinical activities. Prescient noted the quarter included A$2.7 million of June-dated payables and significant pre-payments; it highlighted operating expenditure incurred and settled for the September quarter of A$1.4 million, and said the reported 3.1-quarter runway in section 8.5 is not aligned with budgeted expectations.